Publication: Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels
dc.contributor.author | Bunker, Clareann H. | |
dc.contributor.author | Hokanson, John E. | |
dc.contributor.author | Hamman, Richard F. | |
dc.contributor.author | Demirci, F. Yesim | |
dc.contributor.author | Kamboh, M. Ilyas | |
dc.contributor.buuauthor | Pirim, Dilek | |
dc.contributor.buuauthor | PİRİM, DİLEK | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Moleküler Biyoloji ve Genetik. | |
dc.contributor.orcid | 0000-0002-0522-9432 | |
dc.contributor.researcherid | ABA-4957-2020 | |
dc.contributor.researcherid | HTP-6233-2023 | |
dc.date.accessioned | 2024-07-02T05:31:05Z | |
dc.date.available | 2024-07-02T05:31:05Z | |
dc.date.issued | 2020-12-16 | |
dc.description.abstract | Common variants in the hepatic lipase (LIPC) gene have been shown to be associated with plasma lipid levels; however, the distribution and functional features of rare and regulatory LIPC variants contributing to the extreme lipid phenotypes are not well known. This study was aimed to catalogue LIPC variants by resequencing the entire LIPC gene in 95 non-Hispanic Whites (NHWs) and 95 African blacks (ABs) with extreme HDL-C levels followed by in silico functional analyses. A total of 412 variants, including 43 novel variants were identified; 56 were unique to NHWs and 234 were unique to ABs. Seventy-eight variants in NHWs and 89 variants in ABs were present either in high HDL-C group or low HDL-C group. Two non-synonymous variants (p.S289F, p.T405M), found in NHWs with high HDL-C group were predicted to have damaging effect on LIPC protein by SIFT, MT2 and PP2. We also found several non-coding variants that possibly reside in the circRNA and lncRNA binding sites and may have regulatory potential, as identified in rSNPbase and RegulomeDB databases. Our results shed light on the regulatory nature of rare and non-coding LIPC variants as well as suggest their important contributions in affecting the extreme HDL-C phenotypes. | |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Heart Lung & Blood Institute (NHLBI) -- HL084613 | |
dc.identifier.doi | 10.1371/journal.pone.0243919 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.issue | 12 | |
dc.identifier.uri | https://doi.org/10.1371/journal.pone.0243919 | |
dc.identifier.uri | https://hdl.handle.net/11452/42676 | |
dc.identifier.volume | 15 | |
dc.identifier.wos | 000600176400047 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Public Library Science | |
dc.relation.journal | Plos One | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | African blacks | |
dc.subject | Rare variants | |
dc.subject | Plasma-lipids | |
dc.subject | Risk | |
dc.subject | Loci | |
dc.subject | Hdl | |
dc.subject | Polymorphism | |
dc.subject | Association | |
dc.subject | Disease | |
dc.subject | Population | |
dc.subject | Science & technology | |
dc.subject | Multidisciplinary sciences | |
dc.subject | Science & technology - other topics | |
dc.title | Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 4fe8e2a8-6667-4c54-9c39-a4059fcb6657 | |
relation.isAuthorOfPublication.latestForDiscovery | 4fe8e2a8-6667-4c54-9c39-a4059fcb6657 |
Files
Original bundle
1 - 1 of 1